This reduced F-actin intensity due to antibody treatment is correlated with an increased HIV-1 infection in Fig. 1i, further supporting that PSGL-1 inhibits HIV-1 infection by modulating F-actin intensity. Here, SELPLG is linked to HIV-1 infection.